Tigo Energy (NASDAQ: TYGO) has filed a Form 144 indicating a planned sale of 63,452 shares of common stock, valued at $263,167.17, associated with restricted stock vesting under a registered plan. The vesting date is set for May 19, 2025. This filing serves as a notice of intent to sell rather than a confirmation of an immediate market transaction, with actual sale details expected in future transaction filings.

Federal Realty Investment Trust is breaking ground on the third and final phase of the Willow Grove Shopping Center's $115 million redevelopment. The project at 122 Park Avenue will include 261 residential units, three retail buildings, a 438-stall parking garage, and a mixed-use building, with completion expected in 2028. Existing stores will remain open during construction.

The T. Rowe Price U.S. Equity Research ETF (TSPA), an active ETF, has emerged as a leading performer over the past year among strategies with at least $500 million in AUM and three-year track records. Charging 34 basis points, TSPA has returned 34.2% and aims to achieve long-term capital growth with S&P 500-like sector neutrality while actively selecting and weighting individual securities. This strategy may appeal to investors amid ongoing economic questions about interest rates and inflation.

Dell Technologies is addressing the challenges of AI implementation, such as data differentiation, hybrid workloads, token costs, and infrastructure flexibility, through its expanded AI portfolio. The company is focused on helping organizations transform their data into intelligence to capitalize on the "useful" era of AI. Dell has also announced several enhancements to its AI Data Platform, new Deskside Agentic AI offerings, expanded PowerRack and ExaScale Storage, and broader ecosystem support.

Bragar Eagel & Squire, P.C. has filed a class action lawsuit against United Homes Group, Inc. on behalf of investors who purchased securities between May 19, 2025, and February 22, 2026. The lawsuit alleges that United Homes' controlling shareholder, Nieri, made false and misleading statements and took actions to devalue the company. Investors interested in becoming lead plaintiff must apply by June 9, 2026.

UFP Technologies (NASDAQ: UFPT) announced that Christopher P. Litterio, the company’s General Counsel, Secretary, and Senior Vice President of Human Resources, plans to retire after a transition period. This forthcoming change was disclosed in an 8-K filing. The departure signifies a planned leadership transition in the legal and human resources departments rather than an immediate exit.

VEON's subsidiary, Kyivstar, has acquired six solar power plants in Ukraine for $80.8 million, significantly expanding its renewable energy capacity to 118 MW. This move increases Kyivstar's solar generation by nearly ninefold, aiming to supply 30% of its annual electricity consumption, hedge against rising energy costs, and support Ukraine's energy sector development. The acquisition underscores VEON and Kyivstar's commitment to investing in sustainable infrastructure and operational efficiency in Ukraine.

Costco stores in Sacramento recently sold nursery plants infested with the invasive glassy-winged sharpshooter, an insect known to spread a disease fatal to wine grapes. This discovery has prompted urgent public action from Sacramento County’s agricultural commissioner.

IQVIA Holdings Inc. (NYSE: IQV) announced that its chairman and CEO, Ari Bousbib, will speak at the Jefferies Global Healthcare Conference on June 3, 2026, at 9:20 a.m. ET. A live audio webcast and subsequent replay of his presentation will be available on the IQVIA Investor Relations website. IQVIA is a global leader in clinical research services and healthcare intelligence.

Eli Lilly and Co. is expanding its R&D efforts into infectious diseases by acquiring three vaccine manufacturers for nearly $4 billion. The acquisitions, Curevo Inc., LimmaTech Biologics AG, and Vaccine Company, Inc., focus on developing vaccines for shingles, bacterial pathogens, and Epstein-Barr Virus, respectively. This strategic move aims to prevent diseases at their source and address significant health problems.